1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Veverka, V. Cheng, X. Waters, L.C. Muskett, F.W. Morgan, S. Lesley, A. Griffiths, M. Stubberfield, C. Griffin, R. Henry, A.J. Robinson, M.K. Jansson, A. Ladbury, J.E. Ikemizu, S. Davis, S.J. Carr, M.D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 288 11771 11785 10.1074/jbc.M112.448126 23417675 Structure and interactions of the human programmed cell death 1 receptor. 2013 13245.809 Programmed cell death protein 1 1 man polymer Protein PD-1, hPD-1 no no MPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVR ARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE MPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVR ARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample PDCD1, PD1 9606 Homo sapiens 562 Escherichia coli plasmid pET repository Initial release Database references Database references 1 0 2013-02-27 1 1 2013-03-06 1 2 2013-05-15 BMRB Y RCSB 2012-12-18 REL REL REL structures with the least restraint violations 100 35 2D 1H-15N HSQC 2D 1H-13C HSQC 2D 1H-1H TOCSY 2D 1H-1H NOESY 3D HNCACB 3D CBCA(CO)NH 3D HNCO 3D HCCH-TOCSY 3D 1H-15N TOCSY 3D 1H-13C NOESY 3D 1H-15N NOESY 0.5 mM [U-15N] 25 mM 100 mM 0.5 mM [U-13C; U-15N] 25 mM 100 mM 0.5 mM 25 mM 100 mM 0.125 6.4 ambient 298 K DGSA-distance geometry simulated annealing 1 closest to the average 0.5 mM [U-15N] protein, 25 mM potassium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O 95% H2O/5% D2O 0.5 mM [U-13C; U-15N] protein, 25 mM potassium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O 95% H2O/5% D2O 0.5 mM protein, 25 mM potassium phosphate, 100 mM sodium chloride, 100% D2O 100% D2O Bruker Biospin collection TOPSPIN Goddard data analysis SPARKY Guntert, Mumenthaler and Wuthrich structure solution CYANA Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman structure solution AMBER Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman refinement AMBER 600 Bruker Avance Bruker Avance 800 Bruker Avance Bruker Avance MET 33 n 1 MET 33 A PRO 34 n 2 PRO 34 A PRO 35 n 3 PRO 35 A THR 36 n 4 THR 36 A PHE 37 n 5 PHE 37 A SER 38 n 6 SER 38 A PRO 39 n 7 PRO 39 A ALA 40 n 8 ALA 40 A LEU 41 n 9 LEU 41 A LEU 42 n 10 LEU 42 A VAL 43 n 11 VAL 43 A VAL 44 n 12 VAL 44 A THR 45 n 13 THR 45 A GLU 46 n 14 GLU 46 A GLY 47 n 15 GLY 47 A ASP 48 n 16 ASP 48 A ASN 49 n 17 ASN 49 A ALA 50 n 18 ALA 50 A THR 51 n 19 THR 51 A PHE 52 n 20 PHE 52 A THR 53 n 21 THR 53 A CYS 54 n 22 CYS 54 A SER 55 n 23 SER 55 A PHE 56 n 24 PHE 56 A SER 57 n 25 SER 57 A ASN 58 n 26 ASN 58 A THR 59 n 27 THR 59 A SER 60 n 28 SER 60 A GLU 61 n 29 GLU 61 A SER 62 n 30 SER 62 A PHE 63 n 31 PHE 63 A VAL 64 n 32 VAL 64 A LEU 65 n 33 LEU 65 A ASN 66 n 34 ASN 66 A TRP 67 n 35 TRP 67 A TYR 68 n 36 TYR 68 A ARG 69 n 37 ARG 69 A MET 70 n 38 MET 70 A SER 71 n 39 SER 71 A PRO 72 n 40 PRO 72 A SER 73 n 41 SER 73 A ASN 74 n 42 ASN 74 A GLN 75 n 43 GLN 75 A THR 76 n 44 THR 76 A ASP 77 n 45 ASP 77 A LYS 78 n 46 LYS 78 A LEU 79 n 47 LEU 79 A ALA 80 n 48 ALA 80 A ALA 81 n 49 ALA 81 A PHE 82 n 50 PHE 82 A PRO 83 n 51 PRO 83 A GLU 84 n 52 GLU 84 A ASP 85 n 53 ASP 85 A ARG 86 n 54 ARG 86 A SER 87 n 55 SER 87 A GLN 88 n 56 GLN 88 A PRO 89 n 57 PRO 89 A GLY 90 n 58 GLY 90 A GLN 91 n 59 GLN 91 A ASP 92 n 60 ASP 92 A SER 93 n 61 SER 93 A ARG 94 n 62 ARG 94 A PHE 95 n 63 PHE 95 A ARG 96 n 64 ARG 96 A VAL 97 n 65 VAL 97 A THR 98 n 66 THR 98 A GLN 99 n 67 GLN 99 A LEU 100 n 68 LEU 100 A PRO 101 n 69 PRO 101 A ASN 102 n 70 ASN 102 A GLY 103 n 71 GLY 103 A ARG 104 n 72 ARG 104 A ASP 105 n 73 ASP 105 A PHE 106 n 74 PHE 106 A HIS 107 n 75 HIS 107 A MET 108 n 76 MET 108 A SER 109 n 77 SER 109 A VAL 110 n 78 VAL 110 A VAL 111 n 79 VAL 111 A ARG 112 n 80 ARG 112 A ALA 113 n 81 ALA 113 A ARG 114 n 82 ARG 114 A ARG 115 n 83 ARG 115 A ASN 116 n 84 ASN 116 A ASP 117 n 85 ASP 117 A SER 118 n 86 SER 118 A GLY 119 n 87 GLY 119 A THR 120 n 88 THR 120 A TYR 121 n 89 TYR 121 A LEU 122 n 90 LEU 122 A CYS 123 n 91 CYS 123 A GLY 124 n 92 GLY 124 A ALA 125 n 93 ALA 125 A ILE 126 n 94 ILE 126 A SER 127 n 95 SER 127 A LEU 128 n 96 LEU 128 A ALA 129 n 97 ALA 129 A PRO 130 n 98 PRO 130 A LYS 131 n 99 LYS 131 A ALA 132 n 100 ALA 132 A GLN 133 n 101 GLN 133 A ILE 134 n 102 ILE 134 A LYS 135 n 103 LYS 135 A GLU 136 n 104 GLU 136 A SER 137 n 105 SER 137 A LEU 138 n 106 LEU 138 A ARG 139 n 107 ARG 139 A ALA 140 n 108 ALA 140 A GLU 141 n 109 GLU 141 A LEU 142 n 110 LEU 142 A ARG 143 n 111 ARG 143 A VAL 144 n 112 VAL 144 A THR 145 n 113 THR 145 A GLU 146 n 114 GLU 146 A ARG 147 n 115 ARG 147 A ARG 148 n 116 ARG 148 A ALA 149 n 117 ALA 149 A GLU 150 n 118 GLU 150 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N SER 38 A N SER 6 A O THR 53 A O THR 21 A N ALA 50 A N ALA 18 A O VAL 110 A O VAL 78 A O HIS 107 A O HIS 75 A N THR 98 A N THR 66 A N VAL 44 A N VAL 12 A O THR 145 A O THR 113 A O LEU 142 A O LEU 110 A N GLY 119 A N GLY 87 A O ILE 126 A O ILE 94 A N VAL 64 A N VAL 32 A N TRP 67 A N TRP 35 A O LEU 79 A O LEU 47 35 A ARG 94 0.093 SIDE CHAIN 1 3.12 0.50 120.30 123.42 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 2 3.02 0.50 120.30 123.32 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 2 3.84 0.50 120.30 124.14 A A A NE CZ NH1 ARG ARG ARG 96 96 96 N 4 3.03 0.50 120.30 123.33 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 6 3.10 0.50 120.30 123.40 A A A NE CZ NH1 ARG ARG ARG 114 114 114 N 7 3.36 0.50 120.30 123.66 A A A NE CZ NH1 ARG ARG ARG 96 96 96 N 7 -3.28 0.50 120.30 117.02 A A A NE CZ NH2 ARG ARG ARG 115 115 115 N 8 3.08 0.50 120.30 123.38 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 8 3.55 0.50 120.30 123.85 A A A NE CZ NH1 ARG ARG ARG 115 115 115 N 9 3.24 0.50 120.30 123.54 A A A NE CZ NH1 ARG ARG ARG 148 148 148 N 11 3.30 0.50 120.30 123.60 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 11 3.22 0.50 120.30 123.52 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 12 3.26 0.50 120.30 123.56 A A A NE CZ NH1 ARG ARG ARG 96 96 96 N 12 3.27 0.50 120.30 123.57 A A A NE CZ NH1 ARG ARG ARG 139 139 139 N 15 3.05 0.50 120.30 123.35 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 16 3.88 0.50 120.30 124.18 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 17 3.27 0.50 120.30 123.57 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 17 3.41 0.50 120.30 123.71 A A A NE CZ NH1 ARG ARG ARG 139 139 139 N 18 -3.13 0.50 120.30 117.17 A A A NE CZ NH2 ARG ARG ARG 115 115 115 N 19 3.50 0.50 120.30 123.80 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 20 3.08 0.50 120.30 123.38 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 21 3.30 0.50 120.30 123.60 A A A NE CZ NH1 ARG ARG ARG 148 148 148 N 22 4.01 0.50 120.30 124.31 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 22 3.55 0.50 120.30 123.85 A A A NE CZ NH1 ARG ARG ARG 147 147 147 N 23 3.07 0.50 120.30 123.37 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 23 3.44 0.50 120.30 123.74 A A A NE CZ NH1 ARG ARG ARG 148 148 148 N 25 3.22 0.50 120.30 123.52 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 26 3.04 0.50 120.30 123.34 A A A NE CZ NH1 ARG ARG ARG 114 114 114 N 27 3.27 0.50 120.30 123.57 A A A NE CZ NH1 ARG ARG ARG 139 139 139 N 27 3.16 0.50 120.30 123.46 A A A NE CZ NH1 ARG ARG ARG 147 147 147 N 28 3.46 0.50 120.30 123.76 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 29 3.88 0.50 120.30 124.18 A A A NE CZ NH1 ARG ARG ARG 115 115 115 N 29 -3.11 0.50 120.30 117.19 A A A NE CZ NH2 ARG ARG ARG 115 115 115 N 29 3.02 0.50 120.30 123.32 A A A NE CZ NH1 ARG ARG ARG 148 148 148 N 30 3.26 0.50 120.30 123.56 A A A NE CZ NH1 ARG ARG ARG 148 148 148 N 31 3.01 0.50 120.30 123.31 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 32 3.06 0.50 120.30 123.36 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 33 3.01 0.50 120.30 123.31 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 33 3.43 0.50 120.30 123.73 A A A NE CZ NH1 ARG ARG ARG 94 94 94 N 33 -3.16 0.50 120.30 117.14 A A A NE CZ NH2 ARG ARG ARG 114 114 114 N 34 3.08 0.50 120.30 123.38 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 35 3.76 0.50 120.30 124.06 A A A NE CZ NH1 ARG ARG ARG 139 139 139 N 1 A GLU 84 -68.32 94.55 1 A SER 87 70.02 -60.96 1 A ARG 112 62.60 72.29 2 A SER 60 -81.90 39.66 2 A ARG 104 -154.50 73.61 3 A ASP 85 -85.11 33.46 3 A ASP 92 -142.94 55.40 3 A ARG 94 80.63 -34.13 3 A ASP 105 174.12 142.20 3 A ARG 112 57.49 77.09 4 A ASN 74 75.60 36.79 4 A SER 87 70.29 -61.08 4 A ARG 104 -154.50 73.64 4 A ARG 112 53.63 73.43 4 A LEU 138 68.94 173.88 5 A PRO 35 -58.66 109.18 6 A GLU 84 -68.78 94.51 6 A SER 87 68.05 -25.16 6 A ASP 105 179.76 136.91 7 A ARG 86 -57.66 -7.87 7 A ARG 104 -154.41 73.51 7 A ASP 105 -174.64 147.43 8 A ASN 74 70.53 45.75 8 A SER 87 81.90 -42.45 8 A ARG 104 -154.49 73.28 9 A GLU 61 -78.20 -70.74 9 A ARG 104 -152.44 73.54 9 A ARG 112 48.37 76.92 10 A SER 62 128.96 165.17 10 A ARG 104 -154.58 73.61 10 A ASP 105 -178.76 148.37 10 A ARG 112 55.34 84.96 11 A ASP 85 -152.78 38.93 11 A ARG 104 -154.63 73.65 11 A ARG 112 49.30 72.61 12 A SER 62 84.76 166.84 12 A SER 87 59.78 19.01 12 A GLN 91 56.84 -101.11 12 A ARG 94 -153.63 -18.01 12 A ARG 104 -154.57 73.52 12 A ASP 105 -171.47 145.41 12 A LEU 138 66.84 -178.55 13 A ARG 104 -154.58 73.59 14 A GLU 61 71.40 -67.07 14 A SER 62 176.30 160.49 14 A ASP 105 -178.78 140.68 15 A THR 59 -104.78 -169.54 15 A ASN 74 71.31 46.07 15 A SER 87 75.01 -54.65 15 A ARG 94 77.77 -27.05 15 A ASP 105 -178.37 146.00 16 A ARG 86 -66.09 -77.68 16 A SER 87 67.44 -59.72 16 A ASP 105 -174.89 141.72 16 A ARG 112 51.08 70.42 17 A SER 73 -76.97 21.31 17 A ASP 85 -161.17 41.43 17 A SER 87 78.75 -3.89 17 A ARG 104 -154.60 73.76 18 A THR 36 -171.76 147.72 18 A SER 87 65.33 -26.21 18 A ASP 105 178.99 136.57 19 A GLU 84 -62.68 97.76 19 A ASP 85 -77.99 44.19 19 A ASP 105 -174.22 137.68 20 A SER 87 69.71 -35.28 21 A SER 87 69.22 -47.69 21 A PRO 89 -62.03 -172.82 22 A PHE 37 -161.85 111.99 22 A ASP 105 -170.15 141.60 23 A GLN 91 70.11 -40.62 23 A ARG 104 -154.57 73.69 23 A ASP 105 -173.73 148.67 24 A ASP 105 -177.64 140.82 25 A ARG 86 -101.73 -77.62 25 A SER 87 59.36 -58.56 25 A ARG 104 -154.59 73.66 25 A ASP 105 -173.80 147.53 25 A LEU 138 -55.65 106.96 27 A SER 62 82.07 117.72 27 A SER 87 66.35 -61.18 27 A ARG 112 59.39 73.88 28 A GLU 61 77.87 -30.87 28 A ARG 94 62.43 -35.39 28 A ARG 112 54.97 70.39 29 A ASP 105 -175.47 143.94 29 A ARG 112 54.75 71.33 30 A GLU 61 71.92 -46.81 30 A GLU 84 -68.35 94.45 30 A SER 87 98.49 154.70 30 A GLN 91 -92.14 -143.79 31 A ASP 85 -93.05 35.43 31 A ARG 104 -154.50 73.53 31 A ASP 105 -170.39 136.97 31 A SER 137 -108.33 -166.13 32 A ARG 86 -56.88 -6.07 32 A ARG 104 -154.48 73.65 33 A GLU 61 -93.50 -79.24 33 A ARG 104 -111.53 73.65 33 A ASP 105 175.36 141.30 34 A GLU 61 70.29 -0.76 34 A SER 87 66.44 -45.12 34 A ARG 104 -154.51 73.53 34 A ARG 112 39.70 61.16 35 A SER 60 69.36 -30.95 35 A GLN 91 73.18 -52.58 35 A ARG 104 -154.62 73.71 35 A ASP 105 -178.02 143.02 Programmed cell death protein 1 closest to the average, model 11 Human programmed cell death 1 receptor 1 N N A ARG 114 A ARG 82 HELX_P A SER 118 A SER 86 5 1 5 disulf 2.048 A CYS 54 A SG CYS 22 1_555 A CYS 123 A SG CYS 91 1_555 APOPTOSIS PD-1, APOPTOSIS A SER 38 A SER 6 1 A PRO 39 A PRO 7 -5.63 A PHE 82 A PHE 50 1 A PRO 83 A PRO 51 -12.43 A SER 38 A SER 6 2 A PRO 39 A PRO 7 -2.12 A PHE 82 A PHE 50 2 A PRO 83 A PRO 51 -8.57 A SER 38 A SER 6 3 A PRO 39 A PRO 7 -2.91 A PHE 82 A PHE 50 3 A PRO 83 A PRO 51 -7.29 A SER 38 A SER 6 4 A PRO 39 A PRO 7 -13.00 A PHE 82 A PHE 50 4 A PRO 83 A PRO 51 -10.65 A SER 38 A SER 6 5 A PRO 39 A PRO 7 -4.94 A PHE 82 A PHE 50 5 A PRO 83 A PRO 51 -7.03 A SER 38 A SER 6 6 A PRO 39 A PRO 7 -4.45 A PHE 82 A PHE 50 6 A PRO 83 A PRO 51 -8.55 A SER 38 A SER 6 7 A PRO 39 A PRO 7 -3.14 A PHE 82 A PHE 50 7 A PRO 83 A PRO 51 -10.75 A SER 38 A SER 6 8 A PRO 39 A PRO 7 -5.18 A PHE 82 A PHE 50 8 A PRO 83 A PRO 51 -12.46 A SER 38 A SER 6 9 A PRO 39 A PRO 7 -6.09 A PHE 82 A PHE 50 9 A PRO 83 A PRO 51 -9.40 A SER 38 A SER 6 10 A PRO 39 A PRO 7 -11.96 A PHE 82 A PHE 50 10 A PRO 83 A PRO 51 -11.34 A SER 38 A SER 6 11 A PRO 39 A PRO 7 -11.53 A PHE 82 A PHE 50 11 A PRO 83 A PRO 51 -10.68 A SER 38 A SER 6 12 A PRO 39 A PRO 7 -9.38 A PHE 82 A PHE 50 12 A PRO 83 A PRO 51 -8.80 A SER 38 A SER 6 13 A PRO 39 A PRO 7 -4.75 A PHE 82 A PHE 50 13 A PRO 83 A PRO 51 -6.39 A SER 38 A SER 6 14 A PRO 39 A PRO 7 -4.45 A PHE 82 A PHE 50 14 A PRO 83 A PRO 51 -5.47 A SER 38 A SER 6 15 A PRO 39 A PRO 7 -7.85 A PHE 82 A PHE 50 15 A PRO 83 A PRO 51 -7.66 A SER 38 A SER 6 16 A PRO 39 A PRO 7 -7.51 A PHE 82 A PHE 50 16 A PRO 83 A PRO 51 -8.31 A SER 38 A SER 6 17 A PRO 39 A PRO 7 -10.41 A PHE 82 A PHE 50 17 A PRO 83 A PRO 51 -10.73 A SER 38 A SER 6 18 A PRO 39 A PRO 7 -9.35 A PHE 82 A PHE 50 18 A PRO 83 A PRO 51 -11.57 A SER 38 A SER 6 19 A PRO 39 A PRO 7 -5.38 A PHE 82 A PHE 50 19 A PRO 83 A PRO 51 -9.36 A SER 38 A SER 6 20 A PRO 39 A PRO 7 -7.79 A PHE 82 A PHE 50 20 A PRO 83 A PRO 51 -8.65 A SER 38 A SER 6 21 A PRO 39 A PRO 7 -6.73 A PHE 82 A PHE 50 21 A PRO 83 A PRO 51 -14.32 A SER 38 A SER 6 22 A PRO 39 A PRO 7 -10.07 A PHE 82 A PHE 50 22 A PRO 83 A PRO 51 -11.13 A SER 38 A SER 6 23 A PRO 39 A PRO 7 -7.42 A PHE 82 A PHE 50 23 A PRO 83 A PRO 51 2.75 A SER 38 A SER 6 24 A PRO 39 A PRO 7 -2.46 A PHE 82 A PHE 50 24 A PRO 83 A PRO 51 -12.95 A SER 38 A SER 6 25 A PRO 39 A PRO 7 -8.65 A PHE 82 A PHE 50 25 A PRO 83 A PRO 51 -5.57 A SER 38 A SER 6 26 A PRO 39 A PRO 7 -6.40 A PHE 82 A PHE 50 26 A PRO 83 A PRO 51 -6.30 A SER 38 A SER 6 27 A PRO 39 A PRO 7 -10.07 A PHE 82 A PHE 50 27 A PRO 83 A PRO 51 -10.18 A SER 38 A SER 6 28 A PRO 39 A PRO 7 -6.56 A PHE 82 A PHE 50 28 A PRO 83 A PRO 51 -3.93 A SER 38 A SER 6 29 A PRO 39 A PRO 7 -8.99 A PHE 82 A PHE 50 29 A PRO 83 A PRO 51 -5.80 A SER 38 A SER 6 30 A PRO 39 A PRO 7 -4.26 A PHE 82 A PHE 50 30 A PRO 83 A PRO 51 -11.66 A SER 38 A SER 6 31 A PRO 39 A PRO 7 -6.43 A PHE 82 A PHE 50 31 A PRO 83 A PRO 51 -4.25 A SER 38 A SER 6 32 A PRO 39 A PRO 7 -2.53 A PHE 82 A PHE 50 32 A PRO 83 A PRO 51 -9.32 A SER 38 A SER 6 33 A PRO 39 A PRO 7 -5.17 A PHE 82 A PHE 50 33 A PRO 83 A PRO 51 -4.79 A SER 38 A SER 6 34 A PRO 39 A PRO 7 -11.38 A PHE 82 A PHE 50 34 A PRO 83 A PRO 51 -12.04 A SER 38 A SER 6 35 A PRO 39 A PRO 7 -7.95 A PHE 82 A PHE 50 35 A PRO 83 A PRO 51 -9.03 PDCD1_HUMAN UNP 1 34 Q15116 PPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRA RRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE 34 150 2M2D 34 150 Q15116 A 1 2 118 1 EXPRESSION TAG MET 33 2M2D A Q15116 UNP 1 1 CYS CONFLICT SER 93 2M2D A Q15116 UNP 93 61 4 5 anti-parallel anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel A THR 36 A THR 4 A SER 38 A SER 6 A ALA 50 A ALA 18 A SER 55 A SER 23 A PHE 106 A PHE 74 A VAL 110 A VAL 78 A PHE 95 A PHE 63 A GLN 99 A GLN 67 A LEU 41 A LEU 9 A THR 45 A THR 13 A LYS 135 A LYS 103 A THR 145 A THR 113 A GLY 119 A GLY 87 A SER 127 A SER 95 A PHE 63 A PHE 31 A MET 70 A MET 38 A THR 76 A THR 44 A PHE 82 A PHE 50